Atherosclerosis & Risk Factors Overview

Atherosclerosis & Risk Factors Overview

Brief Overview

  • This note covers aspects of Vascular Disease derived from an audio source.
  • Key focus areas include:
    • Risk factors for atherosclerosis.
    • Differences between Peripheral Arterial Disease (PAD) and Peripheral Venous Disease (PVD).
    • Typical clinical findings.
    • Essential diagnostic tests.
    • Non-pharmacologic and pharmacologic treatment options.

Key Points

  • Main Risk Factors include:

    • Elevated LDL (Low-Density Lipoprotein)
    • Hypertension (high blood pressure)
    • Diabetes Mellitus
    • Smoking
    • Obesity
    • Genetic predisposition
  • Peripheral Arterial Disease (PAD):

    • Clinical presentations: cool, thin skin, intermittent claudication.
  • Peripheral Venous Disease (PVD):

    • Clinical presentations: warm, thick skin, leg swelling.
  • Diagnostic Test:

    • The Ankle-Brachial Index (ABI) is crucial for PAD diagnosis. An ABI value below 0.9 suggests the presence of the disease.
  • Management Options include:

    • Lifestyle modifications
    • Antiplatelet therapy
    • Statins to lower cholesterol
    • Invasive techniques like angiography if required.

Atherosclerosis

  • Defined as the progressive and chronic obstruction of blood flow through the large arteries caused by plaque accumulation.
  • Leads to reduced blood perfusion which can cause vessel occlusion.

Epidemiology

  • Affected Population by Region:
    • United States (≥40 years): approximately 9 million cases (as of 2016 AHA data).
    • Worldwide: approximately 202 million cases combined for PAD and PVD.
    • Canada (example region: Florida): shows high prevalence.

Peripheral Arterial Disease (PAD) vs Peripheral Venous Disease (PVD)

Clinical Presentation & Assessment

  • The “5P’s” of Peripheral Vascular Examination:
    1. Pain: Especially with exertion.
    2. Pallor: Especially upon elevation of the limb.
    3. Pulses: Depletion or absence of distal pulses.
    4. Pressure: Lower ankle systolic pressure compared to brachial pressure.
    5. Paresthesia: Symptoms such as numbness and tingling.

Comparative Features

  • Feature Comparison between PAD and PVD:
    • Primary Problem:
    • PAD: Decreased arterial perfusion to distal tissues.
    • PVD: Decreased venous return causing increased hydrostatic pressure.
    • Typical Pain:
    • PAD: Intermittent claudication (calf pain induced by exercise).
    • PVD: Leg heaviness, swelling, aching.
    • Skin Temperature:
    • PAD: Cool to touch.
    • PVD: Warm to touch.
    • Skin Appearance:
    • PAD: Thin, dry, scaly, hairless; may exhibit pallor.
    • PVD: Thick, brownish discoloration (stasis dermatitis).
    • Edema:
    • PAD: Usually absent.
    • PVD: Prominent peripheral edema.
    • Ulcer Location:
    • PAD: Tips of toes, between toes, dorsal foot; characterized by "punched-out" borders.
    • PVD: Medial shin or ankle; typically shallow, exudative, and irregular borders.
    • Positioning Advice:
    • PAD: Elevate legs downwards to assist arterial flow with gravity.
    • PVD: Elevate legs to facilitate venous return.

Skin & Temperature Findings

  • Arterial Insufficiency:

    • Skin appears cool, thin, dry, and hairless; may show signs of pallor.
  • Venous Insufficiency:

    • Skin appears warm, thickened with brownish discoloration; often edematous.

Intermittent Claudication

Definition

  • Intermittent claudication is defined as muscle pain, cramping, numbness, or fatigue (most frequently in the calf) that occurs during physical exertion and is relieved upon resting briefly.

Ulcer Characteristics

Diagnostic Tests

  • Types and Locations of Ulcers:
    • Arterial Ulcer:
    • Location: Distal toe tips, between toes, dorsal foot.
    • Appearance: Small, deep, well-defined with "punched-out" edges and minimal exudate.
    • Venous Ulcer:
    • Location: Medial shin, ankle.
    • Appearance: Larger, shallow, irregular, often exudative with a brownish wound bed.

Diagnostic Tests Overview

  • Test and Principle:
    1. Ankle-Brachial Index (ABI):
    • Compares ankle systolic blood pressure to brachial systolic blood pressure.
    • ABI < 0.9 indicates a diagnosis of PAD.
    1. Plethysmography:
    • Measures changes in pulse pressure along the leg, frequently via ultrasound.
    • Detects segmental flow reductions.
    1. Treadmill (Exercise) Test:
    • Elicits claudication; demonstrates functional limitations by evaluating onset of pain at specific workloads.
    1. Duplex Ultrasound:
    • Merges B-mode imaging with Doppler flow analysis to visualize stenosis and assess blood velocity.
    1. CT/MR Angiography:
    • Offers cross-sectional images of the arterial lumen to accurately map occlusions.

Treatment Strategies

Non-Pharmacologic Measures

  • Weight Reduction:
    • Aim for ≥10% body weight loss if overweight.
  • Exercise Recommendations:
    • Minimum of 30 minutes of moderate exercise, such as brisk walking, most days to enhance collateral circulation.
  • Dietary Modification:
    • Follow a diet low in saturated fats, high in fiber, and rich in omega-3 fatty acids.
  • Leg Positioning Advice:
    • For PAD: Legs should be positioned downwards to take advantage of gravity in aiding arterial flow.
    • For PVD: Legs should be elevated to promote venous return.
  • Compression Therapy (For PVD):
    • Utilization of graded stockings to reduce edema.

Pharmacologic Therapy

  • Adherence to Medication is critical as untreated PAD/PVD heightens the risk for myocardial infarction, stroke, and lower-extremity amputation.
  • Invasive Options:
    • Catheter angiography is considered the gold standard for guiding endovascular interventions.
Drug Classes and Representative Agents
  • Antihypertensives:
    • Examples include ACE inhibitors, ARBs, and thiazides aimed at lowering blood pressure and reducing wall stress.
  • Antiplatelet Agents:
    • Aspirin (75-325mg daily) to prevent thrombosis.
  • Statins:
    • Atorvastatin, Simvastatin for lowering LDL levels and stabilizing plaque.
  • Beta-Blockers:
    • Metoprolol and Carvedilol to control heart rate and reduce myocardial oxygen demand.